148
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Multimodal Imaging of Parry Romberg Syndrome-associated Panuveitis: A Case Report and Review of Literature

, MD, PhD, , MD, , MD, , MD, PhD & , MD, PhD
Pages 179-186 | Received 08 Feb 2019, Accepted 06 Aug 2019, Published online: 02 Oct 2019

REFERENCES

  • Tolkachjov SN, Patel NG, Tollefson MM. Progressive hemifacial atrophy: a review. Orphanet J Rare Dis. 2015;10(1):39–52. doi:10.1186/s13023-015-0250-9.
  • Bucher F, Fricke J, Neugebauer A, Cursiefen C, Heindl LM. Ophthalmological manifestations of Parry-Romberg syndrome. Surv Ophthalmol. 2016;61(6):693–701. doi:10.1016/j.survophthal.2016.03.009.
  • Moore DB, Randhawa S, Van Gelder RN. Retinitis pigmentosa associated with progressive hemifacial atrophy (parry-romberg syndrome). Retin Cases Brief Rep. 2012;6(1):87–90. doi:10.1097/ICB.0b013e31820885c7.
  • Ehmann D, Riyaz R, Greve M. Central retinal artery occlusion in a child with Parry-Romberg syndrome. Can J Ophthalmol. 2014;49(1):9–10. doi:10.1016/j.jcjo.2013.09.012.
  • Stone J. Parry-Romberg syndrome: A global survey of 205 patients using the Internet. Neurology. 2003;61(5):674–676. doi:10.1212/wnl.61.5.674.
  • Muchnick RS, Aston SJ, Rees TD. Ocular manifestations and treatment of hemifacial atrophy. Am J Ophthalmol. 1979;88(5):889–897. doi:10.1016/0002-9394(79)90567-1.
  • Gass JD, Harbin TS Jr., Del Piero EJ. Exudative stellate neuroretinopathy and Coats’ syndrome in patients with progressive hemifacial atrophy. Eur J Ophthalmol. 1991;1:2–10.
  • Ong K, Billson FA, Pathirana DS, Clifton-Bligh P. A case of progressive hemifacial atrophy with uveitis and retinal vasculitis. Aust N Z J Ophthalmol. 1991;19:295–298.
  • La Hey E, Baarsma GS. Fuchs’ heterochromic cyclitis and retinal vascular abnormalities in progressive hemifacial atrophy. Eye. 1993;7(3)):426–428. doi:10.1038/eye.1993.84.
  • Miller MT, Spencer MA. Progressive hemifacial atrophy. A natural history study. Trans Am Ophthalmol Soc. 1995;93:203–215.
  • Rudolph G, Haritoglou C, Kalpadakis P, et al. Hemifacial atrophy (Parry-Romberg syndrome, #141300) with papillitis, retinal alterations, and restriction of motility. J Aapos. 2002;6(2):126–129.
  • Bellusci C, Liguori R, Pazzaglia A, et al. Bilateral Parry-Romberg syndrome associated with retinal vasculitis. Eur J Ophthalmol. 2003;13(9–10):803–806. doi:10.1177/1120672103013009-1014.
  • Park DH, Kim IT. Patient with Parry-Romberg syndrome complicated by Coats’ syndrome. Jpn J Ophthalmol. 2008;52(6):520–522. doi:10.1007/s10384-008-0597-8.
  • Nasser O, Greiner K, Amer R. Unilateral optic atrophy preceding Coats disease in a girl with Parry-Romberg syndrome. Eur J Ophthalmol. 2010;20:221–223.
  • Yildirim O, Dinc E, Oz O. Parry-Romberg syndrome associated with anterior uveitis and retinal vasculitis. Can J Ophthalmol. 2010;45(3):289–290. doi:10.3129/i09-241.
  • Ayyildiz O, Ayyildiz S, Durukan AH, Sobaci G. Progressive hemifacial atrophy with contralateral uveitis: A case report. Iran Red Crescent Med J. 2015;17(9):161–168.doi: 10.5812/ircmj.16168
  • Hayreh SS. Ocular Vascular Occlusive Disorders. New York, NY: Springer; 2015.
  • Pensler JM, Murphy GF, Mulliken JB. Clinical and ultrastructural studies of Romberg’s hemifacial atrophy. Plast Reconstr Surg. 1990;85:669–674.
  • Bucher F, Fricke J, Cursiefen C, Heindl LM. Trigeminal involvement in Parry–romberg syndrome: an in vivo confocal microscopy study of the cornea. Cornea. 2015;34(4):10–11. doi:10.1097/ICO.0000000000000390.
  • Hayreh SS. Blood flow in the optic nerve head and factors that may influence it. Prog Retin Eye Res. 2001;20:595–624.
  • Miura T, Yamamoto T. Post‐herpetic vitiligo in an 8‐year‐old boy with immunosuppression. J Dermatol. 2014;41(3):270–271. doi:10.1111/1346-8138.12407.
  • Kwon DY, Park MH, Oh K, Ryu HJ, Park KW. Acute unilateral poliosis concurrent with trigeminal autonomic cephalalgia: a possible aetiological association. Australas J Dermatol. 2010;51(1):66–68. doi:10.1111/j.1440-0960.2009.00583.x.
  • Asanad S. Parry–Romberg syndrome with Uhthoff’s phenomena: a spectrum of autoimmune disease? Case Reports Immunol. April 18, 2019;2019:1–3. published online ahead of print. doi:10.1155/2019/1752456.
  • Fea AM, Aragno V, Briamonte C, et al. Parry Romberg syndrome with a wide range of ocular manifestations: a case report. BMC Ophthalmol. 2015;15(1):119–125. doi:10.1186/s12886-015-0093-0.
  • Naumann G, Gass JD, Font RL. Histopathology of herpes zoster ophthalmicus. Am J Ophthalmol. 1968;65(4):533–541. doi:10.1016/0002-9394(68)93869-5.
  • Roberts TV, Francis IC, Kappagoda MB, Dick AD. Herpes zoster chorioretinopathy. Eye. 1995;9(5):594–598. doi:10.1038/eye.1995.146.
  • Amano Y, Ohashi Y, Haruta Y, Kinoshita S, Tano Y, Manabe R. A new fundus finding in patients with zoster ophthalmicus. Am J Ophthalmol. 1986;102(4):532–533. doi:10.1016/0002-9394(86)90087-5.
  • Nakazawa T, Abe T, Ohmura M. Varicella zoster-associated optic neuropathy with choroidal involvement. Neuroophthalmology. 1999;21(1):39–45. doi:10.1076/noph.21.1.39.3923.
  • Korkmaz C, Adapinar B, Uysal S. Beneficial effect of immunosuppressive drugs on Parry-Romberg syndrome: a case report and review of the literature. South Med J. 2005;98(9):940–942. doi:10.1097/01.smj.0000177355.43001.ff.
  • Hung S, Rutar T, Lin S, et al. Severe hypotony associated with Parry-Romberg syndrome. Ophthalmic Surg Lasers Imaging. 2010;42:1–3. doi:10.3928/15428877-20100216-06

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.